Suprotan
Suprotan Brand names, Suprotan Analogs
- Alinam
- Banabil-sintyal
- Banabin
- Banabin-Sintyal
- Banabin-syntyal
- Bisina
- Chlomedinon
- Chlormethazanone
- Chlormethazone
- Chlormezanon
- Chlormezanone [BAN:INN:JAN]
- Chlormezanonum [INN-Latin]
- Clorilax
- Clormetazanone
- Clormetazon
- Clormezanona [INN-Spanish]
- Clormezanone [DCIT]
- Dichloromethazanone
- Dichloromezanone
- Fenarol
- Lobak
- Mio-Sed
- Miorilax
- Muskel
- Muskel-Trancopal
- Myolespen
- Phenarol
- Rexan
- Rilansyl
- Rilaquil
- Rilasol
- Rilassol
- Rilax
- Rillasol
- Supotran
- Suprotan
- Tanafol
- Trancopal
- Trancote
- Tranrilax
- Transanate
- dl-Chlormezanone
Suprotan Brand Names Mixture
- No information avaliable
Suprotan Chemical_Formula
C11H12ClNO3S
Suprotan RX_link
No information avaliable
Suprotan fda sheet
Suprotan msds (material safety sheet)
Suprotan Synthesis Reference
No information avaliable
Suprotan Molecular Weight
273.737 g/mol
Suprotan Melting Point
116.2 oC
Suprotan H2O Solubility
2500 mg/L (hardly soluble)
Suprotan State
Solid
Suprotan LogP
1.208
Suprotan Dosage Forms
No information avaliable
Suprotan Indication
Used in the management of anxiety and in the treatment of muscle spasm.
Suprotan Pharmacology
Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).
Suprotan Absorption
No information avaliable
Suprotan side effects and Toxicity
Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
Suprotan Patient Information
No information avaliable
Suprotan Organisms Affected
Humans and other mammals
